dilazep has been researched along with Diabetes Mellitus in 3 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dilazep (CAS 35898-87-4), a vasodilating agent, was administered to patients with diabetes mellitus (300 mg/day for a minimum of two weeks)." | 7.68 | Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus. ( Jinnai, Y; Kume, S; Onaya, T; Ozaki, Y; Tawata, M; Yatomi, Y, 1993) |
| "Dilazep (CAS 35898-87-4), a vasodilating agent, was administered to patients with diabetes mellitus (300 mg/day for a minimum of two weeks)." | 3.68 | Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus. ( Jinnai, Y; Kume, S; Onaya, T; Ozaki, Y; Tawata, M; Yatomi, Y, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, H | 1 |
| Mu, L | 1 |
| Yang, Z | 1 |
| Shi, Y | 1 |
| Persson, P | 1 |
| Fasching, A | 1 |
| Pihl, L | 1 |
| Palm, F | 1 |
| Ozaki, Y | 1 |
| Jinnai, Y | 1 |
| Yatomi, Y | 1 |
| Tawata, M | 1 |
| Onaya, T | 1 |
| Kume, S | 1 |
3 other studies available for dilazep and Diabetes Mellitus
| Article | Year |
|---|---|
Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.
Topics: CD8-Positive T-Lymphocytes; Cell Death; Diabetes Mellitus; Diabetic Nephropathies; Dilazep; Genes, M | 2023 |
Adenosine reuptake inhibition reduces diabetes-induced glomerular hyperfiltration via the adenosine A2
Topics: Adenosine; Animals; Diabetes Mellitus; Dilazep; Glomerular Filtration Rate; Kidney; Kidney Diseases; | 2023 |
Effects of dilazep on platelet functions and volume change in patients with diabetes mellitus.
Topics: Aged; Arachidonic Acid; Blood Platelets; Blood Volume; Calcium; Diabetes Mellitus; Dilazep; Female; | 1993 |